Oxidative activation of the dietary cancer chemopreventive agent curcumin
Oxidative activation of the dietary cancer chemopreventive agent curcumin
批准号:
8435168
负责人:
Claus Schneider
金额:
$44.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-01 至 2017-12-31
关键词:
AnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsBiochemicalBiologicalBiological AssayBreast Cancer CellCellsChemicalsChemopreventive AgentClinicalClinical TrialsClinical Trials DesignComplementCurcuminCysteineDNADNA AdductionDNA AdductsDietDiseaseDrug KineticsDrug or chemical Tissue DistributionEpoxy CompoundsFractionationGlucuronidesGlutathioneGoalsIn VitroInflammatoryIntestinal CancerIntestinal MucosaIntestinesIsotopesLabelLeadLiver MicrosomesMalignant NeoplasmsMediator of activation proteinMetabolismMethodologyMolecularMolecular Mechanisms of ActionMusNeurodegenerative DisordersOral AdministrationOutcome StudyOxidation-ReductionOxidative StressOxygenPharmaceutical ChemistryPhasePhysiologicalPlantsPlasmaPoisoningPreventionProteinsRandomized Clinical TrialsReactionSignal TransductionStructureSulfenic AcidsTestingTherapeuticTherapeutic EffectTimeTissuesTopoisomerase IITumericadductbaseclinical applicationcysteinesulfenic aciddietary supplementsdisorder preventionimprovedin vitro Assayin vivoinsightnoveloxidationparathyroid hormone-related proteinpolyphenolpublic health relevancequinone methideresearch studysuccesstumorigenic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Curcumin, a polyphenol isolated from the plant turmeric, is recognized for its antioxidant, anti-inflammatory and anti-tumorigenic bioactivities. t is currently being evaluated in multiple clinical trials for the prevention or treatment of inflammatory and neurodegenerative diseases, and also for intestinal cancers. Although a large number of in vitro targets of curcumin have been identified, the precise chemical-molecular mechanism(s) of its biological activities have not been elucidated. We have discovered a novel, previously unrecognized oxidative transformation of curcumin, and we have detected abundant levels of the oxidative metabolites in plasma and intestinal mucosa after oral administration of curcumin to mice. The oxidative transformation of curcumin is rapid, prominent, and gives rise to novel metabolites via reactive intermediates, including a quinone methide and a spiro-epoxide intermediate. The major final product is a dioxygenated cyclopentadione derivative of curcumin. We will test the hypothesis that the products of oxidative transformation are mediators of pharmacological effects of curcumin. In Specific Aim 1 we will determine biological consequences of oxidative transformation of curcumin. Specifically, we will analyze the mechanism of inhibition of reduced and oxidized IKK? by electrophilic and nucleophilic curcumin metabolites, the mechanism of induction of DNA cleavage by topoisomerase II, and protein and DNA adduct formation by the quinone methide intermediate. In Specific Aim 2 we will identify the products and intermediates of oxidative transformation of curcumin and determine their mechanism of formation. In Specific Aim 3 we will determine in vivo metabolism, tissue distribution, and pharmacokinetics of curcumin and its metabolites using a novel LC-MS methodology with quantification by isotopically labeled standards. The concept of oxidative activation could result in a new paradigm of understanding the structure and function of curcumin with important implications for its clinical application as a therapeutic CAM agent.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel pathways in eicosanoid biosynthesis and metabolism
-
批准号:10672176
-
项目类别:
-
资助金额:$47.55万
-
财政年份:2022
-
负责人:Claus Schneider
-
依托单位:
Novel pathways in eicosanoid biosynthesis and metabolism
-
批准号:10330785
-
项目类别:
-
资助金额:$47.55万
-
财政年份:2022
-
负责人:Claus Schneider
-
依托单位:
Novel Pathways of Eicosanoid Metabolism
-
批准号:9445135
-
项目类别:
-
资助金额:$32.17万
-
财政年份:2017
-
负责人:Claus Schneider
-
依托单位:
Oxidative activation of the dietary cancer chemopreventive agent curcumin
-
批准号:8601172
-
项目类别:
-
资助金额:$43.18万
-
财政年份:2013
-
负责人:Claus Schneider
-
依托单位:
Oxidative activation of the dietary cancer chemopreventive agent curcumin
-
批准号:9207754
-
项目类别:
-
资助金额:$40.99万
-
财政年份:2013
-
负责人:Claus Schneider
-
依托单位:
Pharmacokinetics and Metabolism of Oxidized Curcumin
-
批准号:8301157
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2012
-
负责人:Claus Schneider
-
依托单位:
Pharmacokinetics and Metabolism of Oxidized Curcumin
-
批准号:8540399
-
项目类别:
-
资助金额:$7.33万
-
财政年份:2012
-
负责人:Claus Schneider
-
依托单位:
Convergence of the COX-2 and 5-lipoxygenase pathways
-
批准号:7938289
-
项目类别:
-
资助金额:$5.51万
-
财政年份:2009
-
负责人:Claus Schneider
-
依托单位:
Convergence of the Cox-2 and 5-Lipoxygenase Pathways
-
批准号:8501525
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
Convergence of the COX-2 and 5-lipoxygenase pathways
-
批准号:7541465
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
Convergence of the Cox-2 and 5-Lipoxygenase Pathways
-
批准号:9762119
-
项目类别:
-
资助金额:$31.25万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
Convergence of the Cox-2 and 5-Lipoxygenase Pathways
-
批准号:8852624
-
项目类别:
-
资助金额:$31.36万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
Convergence of the Cox-2 and 5-Lipoxygenase Pathways
-
批准号:8370898
-
项目类别:
-
资助金额:$31.36万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
Convergence of the COX-2 and 5-lipoxygenase pathways
-
批准号:7208628
-
项目类别:
-
资助金额:$27.09万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
Convergence of the COX-2 and 5-lipoxygenase pathways
-
批准号:7751846
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
Convergence of the COX-2 and 5-lipoxygenase pathways
-
批准号:7335593
-
项目类别:
-
资助金额:$28.15万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
Convergence of the Cox-2 and 5-Lipoxygenase Pathways
-
批准号:8688263
-
项目类别:
-
资助金额:$31.36万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
Convergence of the Cox-2 and 5-Lipoxygenase Pathways
-
批准号:9918939
-
项目类别:
-
资助金额:$31.25万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
Convergence of the COX-2 and 5-lipoxygenase pathways
-
批准号:8071582
-
项目类别:
-
资助金额:$28.58万
-
财政年份:2007
-
负责人:Claus Schneider
-
依托单位:
海外基金